Literature DB >> 17226074

Remission of primary duodenal adenocarcinoma with liver metastases with S-1 chemotherapy.

Yoshiki Katakura1, Michihiro Suzuki, Mika Kobayashi, Kazunari Nakahara, Nobuyuki Matsumoto, Fumio Itoh.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17226074     DOI： 10.1007/s10620-006-9382-z

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  15 in total

1.  Primary adenocarcinoma of the duodenum: treatment and survival in 89 patients.

Authors:  E Santoro; M Sacchi; F Scutari; F Carboni; F Graziano
Journal:  Hepatogastroenterology       Date:  1997 Jul-Aug

2.  Improving survival in adenocarcinoma of the duodenum.

Authors:  D R Joesting; R W Beart; J A van Heerden; L H Weiland
Journal:  Am J Surg       Date:  1981-02       Impact factor: 2.565

3.  Delayed diagnosis and lower resection rate of adenocarcinoma of the distal duodenum.

Authors:  D Stell; D Mayer; D Mirza; J Buckels
Journal:  Dig Surg       Date:  2005-01-19       Impact factor: 2.588

4.  Development of a novel form of an oral 5-fluorouracil derivative (S-1) directed to the potentiation of the tumor selective cytotoxicity of 5-fluorouracil by two biochemical modulators.

Authors:  T Shirasaka; Y Shimamato; H Ohshimo; M Yamaguchi; T Kato; K Yonekura; M Fukushima
Journal:  Anticancer Drugs       Date:  1996-07       Impact factor: 2.248

Review 5.  Primary adenocarcinoma of the duodenum.

Authors:  I A Spira; A Ghazi; W I Wolff
Journal:  Cancer       Date:  1977-04       Impact factor: 6.860

6.  Surgical treatment of primary duodenal carcinoma: a personal series.

Authors:  D M Scott-Coombes; R C Williamson
Journal:  Br J Surg       Date:  1994-10       Impact factor: 6.939

7.  Primary adenocarcinoma of the duodenum: management and survival in 67 patients.

Authors:  G Barnes; L Romero; K R Hess; S A Curley
Journal:  Ann Surg Oncol       Date:  1994-01       Impact factor: 5.344

8.  Adenocarcinoma of the duodenum with liver metastases. Complete remission and long-term survival with 5-fluorouracil chemotherapy--a case report.

Authors:  M Witham; P R Harnett
Journal:  Am J Clin Oncol       Date:  1996-06       Impact factor: 2.339

9.  Phase II study of oral S-1 for treatment of metastatic colorectal carcinoma.

Authors:  Kuniaki Shirao; Atsushi Ohtsu; Hideho Takada; Yasushi Mitachi; Kosei Hirakawa; Noboru Horikoshi; Takeshi Okamura; Koichi Hirata; Soh Saitoh; Hiroharu Isomoto; Atsushi Satoh
Journal:  Cancer       Date:  2004-06-01       Impact factor: 6.860

10.  Phase II study of S-1, a novel oral fluorophyrimidine derivative, in patients with metastatic colorectal carcinoma. S-1 Cooperative Colorectal Carcinoma Study Group.

Authors:  A Ohtsu; H Baba; Y Sakata; Y Mitachi; N Horikoshi; K Sugimachi; T Taguchi
Journal:  Br J Cancer       Date:  2000-07       Impact factor: 7.640
View more
  4 in total

1.  Successful treatment of duodenal adenocarcinoma with multiple liver metastases by S-1 + irinotecan (CPT-11).

Authors:  Tomoaki Yamasaki; Hiroko Nebiki; Eiji Sasaki; Osamu Kurai
Journal:  Clin J Gastroenterol       Date:  2009-07-01

2.  Duodenal carcinoma at the ligament of Treitz. A molecular and clinical perspective.

Authors:  Peter T Kalogerinis; John E Poulos; Andrew Morfesis; Anthony Daniels; Stavroula Georgakila; Thomas Daignualt; Alexandros G Georgakilas
Journal:  BMC Gastroenterol       Date:  2010-09-17       Impact factor: 3.067

3.  A case of inoperable duodenal cancer achieving long-term survival after multidisciplinary treatment.

Authors:  Takashi Ando; Takeshi Ishikawa; Eiko Imamoto; Etsuko Kishimoto; Kentaro Suzuki; Yutaka Isozaki; Naoyuki Matsumoto; Hirokazu Oyamada; Tsuguhiro Matsumoto; Kazuhiko Uchiyama; Osamu Handa; Tomohisa Takagi; Nobuaki Yagi; Satoshi Kokura; Yuji Naito; Toshikazu Yoshikawa
Journal:  Case Rep Gastroenterol       Date:  2012-02-18

4.  Diagnosis and Treatment of Synchronous Lymphoma and Digestive System Carcinoma: Report of Four Cases and Literature Review.

Authors:  Jingshu Meng; Huaxiong Pan; Xiaoqian Li; Tao Liu; Zijian Liu; Qiuhui Li; Yin Xiao; Xinxiu Liu; Gang Wu; Fang Zhu; Liling Zhang
Journal:  Front Oncol       Date:  2019-12-10       Impact factor: 6.244
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.